Oncolytics Biotech Inc. (ONC.TO)
CAD 1.1
(-2.65%)
CAD 1.1
(-2.65%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - |
| Cost of Revenue | 403 Thousand | 392 Thousand | 452.06 Thousand | 446.18 Thousand | 485.57 Thousand | 95.37 Thousand |
| Gross Profit | -403 Thousand | -392 Thousand | -452.06 Thousand | -446.18 Thousand | -485.57 Thousand | -95.37 Thousand |
| Operating Expenses | 33.79 Million | 26.92 Million | 26.23 Million | 25.45 Million | 20.69 Million | 16.66 Million |
| Selling, General and Administrative Expenses | 16.08 Million | 11.49 Million | 12.86 Million | 12.06 Million | 8.83 Million | 7.08 Million |
| Research and Development Expenses | 17.7 Million | 15.43 Million | 12.92 Million | 12.94 Million | 11.13 Million | 9.41 Million |
| Other Expenses | - | - | 13.31 Million | 12.51 Million | 9.55 Million | 7.24 Million |
| Cost and Expenses | 33.79 Million | 26.92 Million | 26.23 Million | 25.45 Million | 20.69 Million | 16.66 Million |
| Operating Income | -33.79 Million | -28.56 Million | -26.23 Million | -25.45 Million | -20.69 Million | -16.66 Million |
| Interest Expense | - | 528 Thousand | - | - | - | 173.49 Thousand |
| Income Tax Expense | 97 Thousand | 84 Thousand | 49.42 Thousand | -2.95 Million | 12.42 Million | 548.04 Thousand |
| Earnings before Tax | -27.65 Million | -24.75 Million | -26.25 Million | -22.5 Million | -33.12 Million | -16.48 Million |
| Net Income | -27.75 Million | -24.83 Million | -26.3 Million | -19.55 Million | -45.55 Million | -17.03 Million |
| Earnings Per Share Basic | -0.41 | -0.43 | -0.49 | -0.48 | -2.06 | -1.06 |
| Earnings Per Share Diluted | -0.41 | -0.43 | -0.49 | -0.48 | -2.06 | -1.06 |
| Weighted Average Shares Outstanding | 67.62 Million | 58.02 Million | 53.51 Million | 40.33 Million | 22.13 Million | 16.01 Million |
| Weighted Average Shares Outstanding (Diluted) | 67.62 Million | 58.02 Million | 53.51 Million | 40.33 Million | 22.13 Million | 16.01 Million |
| Gross Margin | - | - | - | - | - | - |
| EBIT Margin | - | - | - | - | - | - |
| Profit Margin | - | - | - | - | - | - |
| EBITDA | -33.71 Million | -26.83 Million | -25.8 Million | -25.37 Million | -20.02 Million | -16.39 Million |
| Earnings Before Tax Margin | - | - | - | - | - | - |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - |
| Cost of Revenue | 98 Thousand | 123 Thousand | 107 Thousand | 403 Thousand | 103 Thousand | 96 Thousand |
| Gross Profit | -98 Thousand | -123 Thousand | -107 Thousand | -403 Thousand | -103 Thousand | -96 Thousand |
| Operating Expenses | 7.82 Million | 8.6 Million | 8.74 Million | 33.38 Million | 11.04 Million | 7.16 Million |
| Selling, General and Administrative Expenses | 3.26 Million | 2.86 Million | 4.08 Million | - | 5.13 Million | 3.36 Million |
| Research and Development Expenses | 4.55 Million | 5.74 Million | 4.65 Million | - | 5.81 Million | 3.7 Million |
| Other Expenses | - | - | - | - | - | - |
| Cost and Expenses | 7.92 Million | 8.72 Million | 8.84 Million | 33.79 Million | 11.04 Million | 7.16 Million |
| Operating Income | -7.92 Million | -8.72 Million | -8.84 Million | -33.79 Million | -11.04 Million | -7.16 Million |
| Interest Expense | - | - | - | - | - | - |
| Income Tax Expense | 95 Thousand | 79.72 Thousand | 43 Thousand | 97 Thousand | 7000.00 | 47 Thousand |
| Earnings before Tax | -7.16 Million | -6.89 Million | -3.9 Million | -27.65 Million | -9.91 Million | -7.39 Million |
| Net Income | -7.25 Million | -6.89 Million | -3.94 Million | -27.75 Million | -9.92 Million | -7.44 Million |
| Earnings Per Share Basic | -0.10 | -0.09 | -0.05 | - | -0.14 | -0.12 |
| Earnings Per Share Diluted | -0.10 | -0.09 | -0.05 | - | -0.14 | -0.12 |
| Weighted Average Shares Outstanding | 76.09 Million | 75.24 Million | 73.73 Million | 67.62 Million | 69.8 Million | 64.46 Million |
| Weighted Average Shares Outstanding (Diluted) | 76.09 Million | 75.24 Million | 73.73 Million | 67.62 Million | 69.8 Million | 64.46 Million |
| Gross Margin | - | - | - | - | - | - |
| EBIT Margin | - | - | - | - | - | - |
| Profit Margin | - | - | - | - | - | - |
| EBITDA | -7.82 Million | -8.6 Million | -8.74 Million | - | -11.77 Million | -6.56 Million |
| Earnings Before Tax Margin | - | - | - | - | - | - |
CYBN
NUVSF
NGRRF
ALKEF
HPQFF
ACT